Global Challenges in Animal Vaccines Development
Description: Global Challenges in Animal Vaccines Development Forecasting Demand and Navigating Regulations Jennifer-C. Essolomwa, Regulatory Affairs Officer HealthforAnimals Illustration Shane Tolentino Distinct Mode of Action -Less likely to induce
Related Topics
Download Presentation
"Global Challenges in Animal Vaccines Development" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
slide1. Global Challenges in Animal Vaccines Development Forecasting Demand and Navigating Regulations Jennifer-C. Essolomwa, Regulatory Affairs Officer HealthforAnimals<br>
slide2. Illustration – Shane Tolentino<br>
slide3. Distinct Mode of Action -Less likely to induce resistance
Advancement in Vaccines Technology -Growing number of live and more sophisticated vaccines , innovative administration methods (e.g. needle-free devices)… OPTIMISING ANTIMICROBIAL USE Animal Vaccination for Sustainable Development MITIGATE LIVESTOCK-BASED EMISSIONS Improve Efficiency -Improved livestock productivity, reduced maintenance costs & land use, prevent diseases.<br>
slide4. Universal Goal - Disease prevention & economic protection
Cost Borne By Farmers - Cost-effective solutions
Government Policies - Mandatory immunisation COMMONALITIES Global Livestock Vaccination Practices DIFFERENCES Disease Prevalence - Based on location, climate, and livestock populations
Access to Quality Veterinary Services - Private vs public, veterinarian & extension services , points of sales, cold chain infrastructure, warehousing capacity…
Cultural Practices - Attitude towards vaccination
Economic Status - Purchasing power<br>
slide5. Market Size - 2,5 % of human health pharma
Minimal Public Funding - Cost borne by farmers
Global Outlook - Investments driven by global trends
Multispecies R&D - “One size does not fit all”
Expertise - Veterinary education, development of innovative animal health solutions Animal Health Pharma KEY CONSIDERATIONS<br>
slide6. Predicting Future Needs 4 Ws of FORECASTING WHAT? Which vaccines/strains/volume, presentation…
WHO? Country, regional entity, international organisation…
WHERE? Country to supply
WHEN? When will the request appear<br>
slide7. Strategies – Holistic Approach to Vaccine Security A CALL FOR CONSENSUS ON Better Disease Surveillance
Prevention as the First Line of Defense
Fostering Collaboration<br>
slide8. Overcoming Challenges in International Markets REGULATORY BURDEN Batch Safety & Potency Test Controls (Animal Welfare)
Complex Regulatory Landscape (Clinical Trial Data Req.)<br>
slide9. Strategies - Streamlining Vaccine Approval A CALL FOR CONSENSUS ON Minimise Animal Testing Use
Target Animal Batch Safety Testing
Potency Batch Release Testing
Accelerated Approval Pathways<br>
slide10. Animal vaccines as a tool to reduce the needs for antimicrobial use: Combating antimicrobial resistance requires a combined approach, including vaccines, treatments, and other strategies.
Animal vaccines as a tool to mitigate livestock-based Greenhouse Gas (GHG) emissions: Improving health status of livestock through vaccination could drastically influence emission intensity.
Risks pooling across animal vaccine value chain: Develop robust data on vaccine demand and streamline regulatory processes. Conclusions<br>
slide11. Extensive modelling & research
60+ page report w/ methodology
Dozens of new data points ANIMAL HEALTH DATA Publications ANIMAL VACCINATION Report on 6 major barriers limiting uptake of animal vaccines
50+ page report w/ 80 actionable solutions<br>
slide12. HealthforAnimals Overview Ten Largest Animal Health Companies
Working in 100+ countries 29 Regional & National Associations
Working in -50 countries<br>
slide13. Thank you<br>
slide2. Illustration – Shane Tolentino<br>
slide3. Distinct Mode of Action -Less likely to induce resistance
Advancement in Vaccines Technology -Growing number of live and more sophisticated vaccines , innovative administration methods (e.g. needle-free devices)… OPTIMISING ANTIMICROBIAL USE Animal Vaccination for Sustainable Development MITIGATE LIVESTOCK-BASED EMISSIONS Improve Efficiency -Improved livestock productivity, reduced maintenance costs & land use, prevent diseases.<br>
slide4. Universal Goal - Disease prevention & economic protection
Cost Borne By Farmers - Cost-effective solutions
Government Policies - Mandatory immunisation COMMONALITIES Global Livestock Vaccination Practices DIFFERENCES Disease Prevalence - Based on location, climate, and livestock populations
Access to Quality Veterinary Services - Private vs public, veterinarian & extension services , points of sales, cold chain infrastructure, warehousing capacity…
Cultural Practices - Attitude towards vaccination
Economic Status - Purchasing power<br>
slide5. Market Size - 2,5 % of human health pharma
Minimal Public Funding - Cost borne by farmers
Global Outlook - Investments driven by global trends
Multispecies R&D - “One size does not fit all”
Expertise - Veterinary education, development of innovative animal health solutions Animal Health Pharma KEY CONSIDERATIONS<br>
slide6. Predicting Future Needs 4 Ws of FORECASTING WHAT? Which vaccines/strains/volume, presentation…
WHO? Country, regional entity, international organisation…
WHERE? Country to supply
WHEN? When will the request appear<br>
slide7. Strategies – Holistic Approach to Vaccine Security A CALL FOR CONSENSUS ON Better Disease Surveillance
Prevention as the First Line of Defense
Fostering Collaboration<br>
slide8. Overcoming Challenges in International Markets REGULATORY BURDEN Batch Safety & Potency Test Controls (Animal Welfare)
Complex Regulatory Landscape (Clinical Trial Data Req.)<br>
slide9. Strategies - Streamlining Vaccine Approval A CALL FOR CONSENSUS ON Minimise Animal Testing Use
Target Animal Batch Safety Testing
Potency Batch Release Testing
Accelerated Approval Pathways<br>
slide10. Animal vaccines as a tool to reduce the needs for antimicrobial use: Combating antimicrobial resistance requires a combined approach, including vaccines, treatments, and other strategies.
Animal vaccines as a tool to mitigate livestock-based Greenhouse Gas (GHG) emissions: Improving health status of livestock through vaccination could drastically influence emission intensity.
Risks pooling across animal vaccine value chain: Develop robust data on vaccine demand and streamline regulatory processes. Conclusions<br>
slide11. Extensive modelling & research
60+ page report w/ methodology
Dozens of new data points ANIMAL HEALTH DATA Publications ANIMAL VACCINATION Report on 6 major barriers limiting uptake of animal vaccines
50+ page report w/ 80 actionable solutions<br>
slide12. HealthforAnimals Overview Ten Largest Animal Health Companies
Working in 100+ countries 29 Regional & National Associations
Working in -50 countries<br>
slide13. Thank you<br>